ARTICLE | Company News
ProChon Biotech, Semafore, Multiple Myeloma Research Foundation cancer news
December 11, 2006 8:00 AM UTC
The foundation awarded $1 million grants to Semafore and ProChon. The grants will be used to develop Semafore's SF1126, a phosphoinositide 3-kinase (PI3K) inhibitor, and ProChon's PRO-001, an antibo...